Loading company…
ID 415099985 · FY 2022–2024 · 3 years
1.2 კომპანიის ძირითად საქმიანობას წარმოადგენს: - საბითუმო ვაჭრობა ფარმაცევტული საქონლითთავისუფალ ინდუსტრიულ ზონაში 1.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|
| Total Revenue | 3,317 | 4,969 | 3,810 | +7.2% |
| Total COGS | -1,895 | -3,468 | -2,150 | +6.5% |
| Gross Profit | 1,422 | 1,501 | 1,661 | +8.1% |
| Gross Margin | 42.9% | 30.2% | 43.6% | |
| Total Operating Expenses | -444 | -63 | -173 | -37.5% |
| EBITDA | 978 | 1,438 | 1,487 | +23.3% |
| EBITDA Margin | 29.5% | 28.9% | 39.0% | |
| Total D&A | 0 | -11 | -9 | -15.4% |
| EBIT / Operating Income | 978 | 1,428 | 1,478 | +23.0% |
| Total Other Income | 209 | -77 | 60 | -46.5% |
| Profit Before Tax | 1,187 | 1,351 | 1,538 | +13.8% |
| Total Income Tax | 0 | 0 | 0 | |
| Net Profit / (Loss) | 1,140 | 1,340 | 1,538 | +16.1% |
| Net Margin | 34.4% | 27.0% | 40.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.